Author Archives: collabrx

CollabRx Announces Receipt of NASDAQ Notice of Noncompliance for Bid Price

San Francisco, CA – June 5, 2015 – CollabRx, Inc. (NASDAQ: CLRX) (herein “CLRX” or “the Company”), announced today that it received a letter from The NASDAQ Stock Market LLC (“Nasdaq”) stating that the bid price of the Company’s common stock for the last 30 consecutive business days had closed below the minimum $1.00 per share […]


SAN FRANCISCO, CA – September 24, 2015 – CollabRx, Inc. (“CollabRx”) (NASDAQ: CLRX) today announced that the registration statement on Form S-4 and the definitive joint proxy statement/prospectus contained therein, regarding CollabRx’s proposed merger with Medytox Solutions, Inc. (“Medytox”) (OTCQB: MMMS), has been declared effective by the Securities and Exchange Commission (the “SEC”). CollabRx will hold […]


SAN FRANCISCO, CA – October 22, 2015 – As previously announced,CollabRx, Inc. (“CollabRx”) (NASDAQ: CLRX) will hold a special meeting of its stockholders on Wednesday, October 28, 2015, to consider and act on several proposals recommended by CollabRx’s board and management regarding its proposed merger with Medytox Solutions, Inc. (“Medytox”) (OTCQB: MMMS). The registration statement on Form […]

CollabRx Stockholders Approve Merger With Medytox Solutions

SAN FRANCISCO, Oct. 30, 2015 (GLOBE NEWSWIRE) — CollabRx, Inc. (“CollabRx”) (NASDAQ:CLRX) announced today it held its Special Meeting of Stockholders to approve the following proposals: (1) the issuance of shares of CollabRx common stock and other securities exercisable or convertible for shares of CollabRx common stock in connection with the proposed merger with Medytox […]

CollabRx Chief Medical Officer to Moderate Panel at Personalized Medicine World Conference (PMWC) 2016

Dr. George Lundberg and panelists to discuss Practicing Pathologists in Personalized Medicine SAN FRANCISCO, CA – December 10,  2015 – CollabRx, Inc. a leading clinical decision support company and wholly owned subsidiary of Rennova Health, Inc. (NASDAQ: RNVA) today announced that its Chief Medical Officer, George Lundberg, MD, will chair this year’s Personalized Medicine World Conference, Silicon Valley session titled, “The […]

CollabRx Announces Adrienne Craig-Kennard as Vice President of Global Business Development and Strategic Alliances

Veteran International Business Development Executive to Lead Organization’s Growth Efforts SAN FRANCISCO, Jan. 19, 2016 (GLOBE NEWSWIRE) – CollabRx, Inc., a leading clinical decision support company and wholly owned subsidiary of Rennova Health, Inc. (NASDAQ:RNVA) today announced Adrienne Craig-Kennard will serve as Vice President of Global Business Development and Strategic Alliances. Craig-Kennard, an expert in international business development […]

Expert Affiliations

The CollabRx network of independent advisors is comprised of leading physicians, scientists, and researchers from the nation’s most prestigious academic and medical institutions as well as thought leaders spanning diverse backgrounds. Banner MD Anderson Cancer Center,Gilbert, AZ Brigham And Women’s Hospital Cleveland Clinic Lerner College of Medicine Dana-Farber Cancer Institute Fred Hutchinson Cancer Research Center […]

Leadership Team

George D. Lundberg, MD, Editor-In-Chief, Chair of the Editorial Advisory Board, & Chief Medical Officer In addition to serving as Editor-In-Chief for CollabRx, Dr. Lundberg is President and Chair of the Board of Directors of The Lundberg Institute, a Consulting Professor at Stanford University, and Editor at Large for Medscape from WebMD. Dr. Lundberg has more […]


CollabRx was co-founded in 2008 by a Silicon Valley tech pioneer/survivor of metastatic cancer and a Stanford professor with an expertise in biocomputing and Artificial Intelligence. They understood from personal experience that incredible amounts of information was available to patients and physicians over the “Cancer Internet”, but very little of it was truly personalized, actionable, […]


CollabRx is a clinical decision-support company delivering expert solutions in precision oncology that enable physicians, laboratories, payers, and providers to achieve standardized, evidence-based care and superior clinical outcomes. Our mission is to organize the world’s knowledge in molecular medicine and make it universally acceptable and useful. To accomplish our mission, CollabRx is changing the way […]